Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3725-3730

  Goto, Isao ^a   Yoneda, Shuichi ^a   Yamamoto, Mitsunobu ^a   Kawajiri, Kaname ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CIGARETTE SMOKE; CYTOCHROME P450; DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; FEMALE; GENOTYPE; GERM LINE; HISTOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SURVIVAL RATE;

ADULT; AGED; BENZO(A)PYRENE; CARCINOMA, NON-SMALL-CELL LUNG; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENES, P53; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PROGNOSIS; SURVIVAL RATE;

EID: 0029765583     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Shimada, T., Yun, C-H., Yamazaki, H , Gautier, J-C., Beaune, P. H., and Guengerich, F. P. Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens Mol. Pharmacol., 41: 856-864, 1992
2. Mannervik, B , and Danielson, U. H. Glutathione transferase, structure and catalytic activity. Crit Rev. Biochem. Mol. Biol., 23 281-337, 1988
3. Nebert, D. W. Role of genetics and drug metabolism in human cancer risk Mutat. Res., 247: 259-266, 1991
4. Kawajin, K , and Fujii-Kuriyama, Y. P450 and human cancer. Jpn J. Cancer Res., 82: 1325-1335, 1991.
5. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett., 263: 131-133, 1990
6. Hayashi, S-I., Watanabe, J., Nakachi, K., and Kawajiri, K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 IA1 gene J Biochem. (Tokyo). 110: 407-411, 1991.
7. Kawajiri, K , Nakachi, K , Imai, K , Watanabe, J., and Hayashi, S-I The CYPIAI gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14: 77-87, 1993.
8. Nakachi, K., Imai, K., Hayashi, S-I., Watanabe, J., and Kawajiri, K. Genetic susceptibility to squamous cell carcinoma of the lung in relation 10 cigarette smoking dose. Cancer Res , 51: 5177-5180, 1991.
9. Nakachi, K , Imai, K , Hayashi, S-I., and Kawajiri, K. Polymorphisms of the CYPIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population Cancer Res., 53: 2994-2999, 1993.
10. Hayashi, S-I., Watanabe, J , and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J. Cancer Res . 83: 866-870, 1992
11. Petersen, D D., McKinney, C. E , Ikeya, K., Smith, H. H., Bale, A. E , McBride, O W., and Nebert, D. W Human CYPIAI gene: cosegregation of the enzyme inducibility phenotype and RFLP Am. J. Hum Genet., 48: 720-725, 1991
12. Crofts, F., Taioli, E., Trachman, J , Cosma, G. N , Currie, D , Toniolo, P , and Garte, S J Functional significance of different human CYPIAI genotypes Carcinogenesis (Lond), 15: 2961-2963, 1994.
13. Seidegard, J., Vorachek, W. R., Pero, W. R., and Pearson, W. R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl Acad Sci. USA, 85: 7293-7297, 1988.
14. Yokota, J., and Sugimura, T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J , 7 920-925, 1993-
15. Weinberg, R. A Tumor suppressor genes Science (Washington DC), 254: 1138-1145, 1991
16. Takahashi, T., Nau, M. M , Chiba, I., Birrer, M J., Rosenberg, R. K., Vinocour, M , Levitt, M , Pass, H., Gazdar, A. F., and Minna, J. D p53 a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989
17. Kishimoto, Y., Murakami, Y , Shiraishi, M., Hayashi, K., and Sekiya, T Aberrations of p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res , 52 4799-4804, 1992.
18. Chiba, I , Takahashi, T , Nau, M. N., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D , Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J , Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer Oncogene, 5: 1603-1610, 1990
19. Brauch, H , Johnson, B., Hovis, J., Yano, T., Gazdar, A , Pettengill, O , Graziano, S., Sorenson, G., Poiesz, B., Minna, J., Linehan, M., and Zbar, B. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small cell carcinoma of the lung. N. Eng. J. Med., 317: 1109-1113, 1987.
20. Kok, K., Osinga, J., Carritt, B , Davis, M., van der Hout, A , van der Veen, A., Landsvater, R., de Leij, L., Berendsen, H., Postmus, P., Poppema, S., and Buys, C Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330: 578-581, 1987
21. Yokota, A., Wada, M , Shimosato, Y., Terada, M., and Sugimura T. Loss of heterozygosity on chromosome 3, 13, and 17 in small cell carcinoma and chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84: 9252-9256, 1987.
22. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T , Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer. J Natl. Cancer Inst., 85: 2018-2023, 1993.
23. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K , Nakamura, Y., Ueda, R , and Takahashi, T. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res , 53: 1-4, 1993.
24. Mitsudomi, T., Steinberg, S M., Oie, H. K , Mulshine, J L , Phelps, R., Viallet, J., Pass, H , Minna, J. D., and Gazdar, A. F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res , 51: 4999-5002, 1991.
25. Slebos, R J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A , van Zandwijk, N., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Eng. J. Med., 323: 561-565, 1990.
26. Sugio, K , Ishida, T., Yokoyama, H., Inoue, T., Sugimachi, K., and Sasazuki, T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52: 2903-2906, 1992.
27. McLaren, R , Kuzu, I., Dunnill, M., Harris, A., Lane, D., and Gatter, K. C The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer , 66: 735-738, 1992
28. Kawajiri, K., Eguchi, H., Nakachi, K , Sekiya, T., and Yamamoto, M. Association of CYPIAI germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res., 56: 72-76, 1996.
29. Okada, T., Kawashima, K , Fukushi, S., Minakuchi, T., and Nishimura, S Association between a cytochrome CYPIAI genotype and incidence of lung cancer. Pharmacogenetics, 4: 333-340, 1994
30. WHO. Histological typing of lung tumors. Am. J. Clin. Pathol., 77: 123-136, 1982.
31. Oken, M. M , Creech, R. H., Tormey, D. C., Horton, J., Davis, T E., McFadden, E. T., and Carbone, P P. Toxicity and response criteria of the Eastern Cooperative Oncology Group Am. J. Clin Oncol , 5: 649-655, 1982.
32. Moutain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl.): 225S-233S, 1986.
33. Comstock, K. E , Sanderson, J. S., Clafin, G., and Henner, W. D. GST1 gene deletion determined by PCR Nucleic Acids Res., 18: 3670, 1990
34. Groppi, A., Coutelle, C , Fleury, B., Iron, A , Begueret, J., and Couzigous, P. Glutathione S-transferase class in French alcoholic cirrhotic patients. Hum. Genet., 87: 628-630, 1991.
35. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc , 53: 457-481, 1958
36. Mantel, N Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
37. Cox, D. R Regression models and life tables. JR. Stat Soc., 34: 187-220, 1972.
38. Takahashi, T., Carbone, D., Takahashi, T , Nau, M M., Hida, T , Linnoila, I., Ueda, R , and Minna, J. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res., 52: 2340-2343, 1992
39. Klein, N , Vignaud, J. M., Sadmi, M., Plenat, F., Borelly, J., Duprez, A., Martinet, Y., and Martinet, N. Squamous metaplasia expression of proto-oncogenes and p53 in lung cancer patients Lab Invest., 68: 26-32, 1993.
40. Sozzi, G., Miozzo, M., Donghi, R., Pillotti, S., Cariani, C. T , Pastorino, U., Porta, G. P , and Pierotti, M. Deletion of 17p and p53 mutations in preneoplastic lesions of the lung Cancer Res., 52 6079-6082, 1992.
41. Marchetti, A., Buttitta, F., Merlo, G., Diella, F., Pellegrini, S , Pepe, S., Macchiarini, P., Chella, A., Angeletti, A., Callahan, R., Bistocchi, M., and Squartini, F. p53 alterations in non-small cell lung cancers correlate with metastastic involvement of hilar and mediastinal lymph nodes. Cancer Res., 53 2846-2851, 1993.